NCT06335901

Brief Summary

This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop predictive model in patients with CHD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 22, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 28, 2024

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

2 years

First QC Date

March 22, 2024

Last Update Submit

April 14, 2025

Conditions

Coronary Heart Disease

Outcome Measures

Primary Outcomes (1)

  • Death （All-cause mortality、Cardiac mortality ）

    5 years of follow-up deaths occurred during this period

Secondary Outcomes (1)

  • Major adverse cardiovascular events

    5 years of follow-up deaths occurred during this period

Study Arms (1)

2

Drug: Drug:Standard therapy

Interventions

Drug:Standard therapyDRUG

Percutaneous coronary Intervention

2

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with coronary heart disease hospitalized at the First Affiliated Hospital of Xinjiang Medical University.

You may qualify if:

  • Patients diagnosed with Coronary Heart Disease (CHD) admitted to the First Affiliated Hospital of Xinjiang Medical University.
  • The diagnosis is based on clinical assessments, including symptomatic evaluation, electrocardiographic findings, and coronary angiography.

You may not qualify if:

  • We excluded patients who had serious heart failure, malignant tumor，rheumatic heart disease, valvular heart disease, congenital heart disease, pulmonary heart disease and serious dysfunction of the liver or kidney.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 630000, China

Location

MeSH Terms

Conditions

Coronary Disease

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University

Study Record Dates

First Submitted

March 22, 2024

First Posted

March 28, 2024

Study Start

February 1, 2020

Primary Completion

January 31, 2022

Study Completion

April 30, 2022

Last Updated

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)